Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03734393 · ClinicalTrials.gov registry record · NA
HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
A NA study of HIV, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 20
- Study locations
NCT03734393: Active NA study of HIV, sponsored by Johns Hopkins University.
NCT03734393 is a NA study of HIV that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 80 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03734393, a NA study of HIV, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to determine if an HIV-infected donor liver (HIVD+) transplant is safe with regards to major transplant-related and HIV-related complications
Primary Outcome
Time (in days) to first of any of the following events: death or graft failure or SAE or HIV breakthrough or opportunistic infection
Conditions Studied
Interventions
- OTHER HIVD+/R+
Study Locations (20)
Illinois
- Northwestern University - Chicago
- Rush University Medical Center - Chicago
- University of Illinois at Chicago - Chicago
New York
- Icahn School of Medicine at Mount Sinai - New York
- Columbia University Medical Center - New York
- Weill Cornell Medical College - New York
California
- University of California, San Diego - San Diego
- University of California, San Francisco - San Francisco
Maryland
- University of Maryland, Institute of Human Virology - Baltimore
- Johns Hopkins University - Baltimore
Alabama
- University of Alabama, Birmingham - Birmingham
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Connecticut
- Yale University School of Medicine - New Haven
District of Columbia
- MedStar Georgetown Transplant Institute - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT03734393 still lists
NCT03734393 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which HIVD+/R+ is the first listed.
NCT03734393 names 20 study sites across 14 states, led by Illinois, New York, California.
Frequently Asked Questions
What is clinical trial NCT03734393 about?
NCT03734393 is a clinical study titled "HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients". The primary objective of this study is to determine if an HIV-infected donor liver (HIVD+) transplant is safe with regards to major transplant-related and HIV-related complications
What is the current status of trial NCT03734393?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2019-01-04. Estimated completion is 2026-04-30.
What conditions does trial NCT03734393 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT03734393?
The interventions under investigation include: HIVD+/R+ (OTHER).
Who is sponsoring clinical trial NCT03734393?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03734393 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03734393's enrollment target sits among peer trials
80 175th of 303 higher than 124 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI